Pfizer's ( PFE ) stock moved higher in Tuesday's pre-market trading after the pharmaceutical giant issued an upbeat full-year outlook for 2025. The company projected annual sales between $61 billion and $64 billion, with earnings per share estimates at $2.80 to $3 — both metrics coming in line with Wall Street projections.

Additionally, the company reaffirmed its 2024 full-year guidance, estimating earnings per share between $2.75 and $2.95.

Market Domination hosts Julie Hyman and Josh Lipton break down the details.

To watch more expert insights and analysis on the latest market action, check out more Market Domination here .

This post was written by Angel Smith